Key Drivers
- Net-cash cushion
- Quarterly profit rebound
- High operating burn
AIAI Summary
Schrödinger's pivot from internal, cash-burning drug programs to a capital-efficient, high-margin software-and-partnerships model reframes the investment case toward enterprise SaaS-style ARR and margin recovery—its success hinges on converting existing high-value proofs-of-concept into scaled, repeatable software contracts while realizing announced $70M+ run-rate savings. The key risk is execution/timing: if enterprise scale-ups stall or revenue recognition remains concentrated, the company can quickly revert to cash burn and dilution, so require multiple consecutive quarters of software ARR growth and sustained positive operating EBITDA before increasing exposure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Net-cash cushion
- •Quarterly profit rebound
- •High operating burn
SDGR has a solid net-cash/liquidity cushion and a strong quarter-to-date profit rebound, but large annual operating losses and heavy R&D/SG&A create execution risk until sustained annual profitability is achieved.
Price Behavior
Key Price Behavior Insights:
- •Price below SMA
- •Lower highs
- •Modest pullback
Stock shows mild short-term weakness—closing at $12.02 below the last month SMA (~$12.30) after an ~8% pullback from the early‑March high, capped near $13.0–$13.2 with support around $11.2–$11.3.
~8% decline from the early‑March peak (~$13.12) into 2026‑03‑20
Sentiment & News
Key News Insights:
- •Revenue momentum
- •Active outreach
- •Equity hiring
Schrödinger reported robust 2025 revenue growth alongside active investor outreach and selective equity‑backed hiring, signaling momentum and focused corporate initiatives ahead of its 2026–2028 targets.
The combination of solid top-line growth, renewed institutional interest, and targeted inducement grants should support share sentiment as the company executes toward its 2026 outlook and 2028 objectives
Similar Companies in Healthcare
Other companies in the same sector with AI ratings